Eric Adams
Chief Executive Officer at INMED PHARMACEUTICALS INC.
Net worth: 11 693 $ as of 30/06/2024
Eric Adams active positions
| Companies | Position | Start | End |
|---|---|---|---|
| INMED PHARMACEUTICALS INC. | Director/Board Member | 16/06/2016 | - |
| Chief Executive Officer | 16/06/2016 | - | |
| President | 16/06/2016 | - |
Career history of Eric Adams
Former positions of Eric Adams
| Companies | Position | Start | End |
|---|---|---|---|
Ronin8 Technologies Ltd.
 Ronin8 Technologies Ltd. Environmental ServicesIndustrial Services Ronin8 Technologies Ltd. provides materials recovery facilities. It captures the metals in electronic waste without destroying the non-metals. The company was founded by Bruce Sifton and Peter Holgate in 2015 and is headquartered in Vancouver, Canada. | Chief Executive Officer | 01/11/2014 | 01/02/2015 |
enGene, Inc.
 enGene, Inc. BiotechnologyHealth Technology enGene, Inc. develops therapeutic solutions for the treatment of metabolic diseases. It operates as a biotechnology company which develops a mucosal immunotherapy platform for treating several prevalent, chronic diseases including inflammatory bowel disease and diabetes. The firm also develops proprietary, non-integrating biopolymer based nucleotide DNA and siRNA delivery technology that facilitates localized delivery of immune-modulating proteins to the intestinal mucosa for treating various immune disorders. The company was founded in 1999 by Anthony T. Cheung, John C. Brown, Timothy J. Kieffer, and Francis John Gargiulo and is headquartered in Vancouver, Canada. | Director/Board Member | 25/05/2011 | 01/07/2013 |
| Chief Executive Officer | 15/03/2004 | 01/07/2013 | |
| President | 15/03/2004 | 25/10/2011 | |
QLT, Inc.
 QLT, Inc. Miscellaneous Commercial ServicesCommercial Services QLT, Inc. is a biotechnology company, which engages in the development and commercialization of innovative ocular products that address the unmet medical needs of patients and clinicians worldwide. It also focuses on developing synthetic retinoid program for the treatment of certain inherited retinal diseases. The company was founded by Julia G. Levy and John C. Brown on February 3, 1981 and is headquartered in Vancouver, Canada. | Sales & Marketing | 01/02/1998 | 01/12/2002 |
| ABBOTT LABORATORIES | Corporate Officer/Principal | 01/08/1992 | 01/08/1996 |
| FRESENIUS SE & CO. KGAA | Corporate Officer/Principal | 01/06/1988 | 01/06/1992 |
Training of Eric Adams
| University of South Carolina | Graduate Degree |
| University of Southern Indiana | Undergraduate Degree |
Statistics
International
| Canada | 5 |
| United States | 4 |
| Germany | 2 |
Operational
| Chief Executive Officer | 3 |
| Director/Board Member | 2 |
| President | 2 |
Sectoral
| Health Technology | 5 |
| Consumer Services | 3 |
| Commercial Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 3 |
|---|---|
| ABBOTT LABORATORIES | Health Technology |
| FRESENIUS SE & CO. KGAA | Health Technology |
| INMED PHARMACEUTICALS INC. | Health Technology |
| Private companies | 3 |
|---|---|
enGene, Inc.
enGene, Inc. BiotechnologyHealth Technology enGene, Inc. develops therapeutic solutions for the treatment of metabolic diseases. It operates as a biotechnology company which develops a mucosal immunotherapy platform for treating several prevalent, chronic diseases including inflammatory bowel disease and diabetes. The firm also develops proprietary, non-integrating biopolymer based nucleotide DNA and siRNA delivery technology that facilitates localized delivery of immune-modulating proteins to the intestinal mucosa for treating various immune disorders. The company was founded in 1999 by Anthony T. Cheung, John C. Brown, Timothy J. Kieffer, and Francis John Gargiulo and is headquartered in Vancouver, Canada. | Health Technology |
QLT, Inc.
QLT, Inc. Miscellaneous Commercial ServicesCommercial Services QLT, Inc. is a biotechnology company, which engages in the development and commercialization of innovative ocular products that address the unmet medical needs of patients and clinicians worldwide. It also focuses on developing synthetic retinoid program for the treatment of certain inherited retinal diseases. The company was founded by Julia G. Levy and John C. Brown on February 3, 1981 and is headquartered in Vancouver, Canada. | Commercial Services |
Ronin8 Technologies Ltd.
Ronin8 Technologies Ltd. Environmental ServicesIndustrial Services Ronin8 Technologies Ltd. provides materials recovery facilities. It captures the metals in electronic waste without destroying the non-metals. The company was founded by Bruce Sifton and Peter Holgate in 2015 and is headquartered in Vancouver, Canada. | Industrial Services |
- Stock Market
- Insiders
- Eric Adams
- Experience
